These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Greene J; Banasr M; Lee B; Warner-Schmidt J; Duman RS Neuropsychopharmacology; 2009 Oct; 34(11):2459-68. PubMed ID: 19553916 [TBL] [Abstract][Full Text] [Related]
9. Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment. Saenz del Burgo L; Cortés R; Mengod G; Montaña M; García del Caño G; Sallés J Eur Neuropsychopharmacol; 2013 Mar; 23(3):229-39. PubMed ID: 22591911 [TBL] [Abstract][Full Text] [Related]
10. Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain. Orrico-Sanchez A; Guiard BP; Manta S; Callebert J; Launay JM; Louis F; Paccard A; Gruszczynski C; Betancur C; Vialou V; Gautron S Transl Psychiatry; 2023 Sep; 13(1):302. PubMed ID: 37775532 [TBL] [Abstract][Full Text] [Related]
11. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment. Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180 [TBL] [Abstract][Full Text] [Related]
12. Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. McAvoy K; Russo C; Kim S; Rankin G; Sahay A Hippocampus; 2015 Nov; 25(11):1429-46. PubMed ID: 25850664 [TBL] [Abstract][Full Text] [Related]
13. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test. Rogóż Z; Kabziński M; Sadaj W; Rachwalska P; Gądek-Michalska A Pharmacol Rep; 2012; 64(6):1391-9. PubMed ID: 23406749 [TBL] [Abstract][Full Text] [Related]
14. Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise. Micheli L; Ceccarelli M; D'Andrea G; Tirone F Brain Res Bull; 2018 Oct; 143():181-193. PubMed ID: 30236533 [TBL] [Abstract][Full Text] [Related]
15. Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine. Kobayashi K; Ikeda Y; Suzuki H Mol Brain; 2011 Mar; 4():12. PubMed ID: 21410937 [TBL] [Abstract][Full Text] [Related]
16. Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression. Mendez-David I; Tritschler L; Ali ZE; Damiens MH; Pallardy M; David DJ; Kerdine-Römer S; Gardier AM Neurosci Lett; 2015 Jun; 597():121-6. PubMed ID: 25916883 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Huang GJ; Herbert J Biol Psychiatry; 2006 Apr; 59(7):619-24. PubMed ID: 16325782 [TBL] [Abstract][Full Text] [Related]
19. Requirement of hippocampal DG nNOS-CAPON dissociation for the anxiolytic and antidepressant effects of fluoxetine. Shi HJ; Wu DL; Chen R; Li N; Zhu LJ Theranostics; 2022; 12(8):3656-3675. PubMed ID: 35664081 [No Abstract] [Full Text] [Related]
20. Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain. de Gandarias JM; Echevarría E; Acebes I; Abecia LC; Casis O; Casis L Brain Res; 1999 Jan; 817(1-2):236-40. PubMed ID: 9889376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]